Patients warned of dangers of Chinese medicines

doi:10.1136/bmj.323.7316.770e

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

This article has a correction

Please see: New house officers lack clinical skills

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Mark Gould

London

Practitioners of traditional Chinese medicine have agreed to cooperate with the Department of Health to improve the safety of traditional medicines after concerns that they may contain potentially toxic or carcinogenic ingredients.

Last week the Committee on Safety of Medicines said that random tests were still finding banned substances such as mercury and arsenic in traditional Chinese medicines sold in the United Kingdom, despite previous warnings. Some medicines also contained steroids, even though the label did not declare it.

Banned products containing the herb aristolochia, which has been associated with two cases of kidney disease in the United Kingdom in 1999, are also still …